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Many viral infections persist indefi  nitely after 
acute infection and may give rise to consider-
able clinical problems. Chronic viral infection is 
established despite expansion of antigen- specifi  c 
CD8 T cells, which often control viral replica-
tion during acute infection (1, 2).   Although 
exhaustion of antigen-specifi  c CD8 T cells has 
been invoked as one reason for pathogen per-
sistence (3), viruses also persist in situations in 
which CD8 T cell functions are not completely 
compromised (4–7). Current evidence suggests 
that maintenance of the CD8 T cell popula-
tion responding to chronic infection is depen-
dent on antigen (8–10). This requirement fi  ts 
with evidence that virus-specifi  c CD8 T cell 
responses decay in hepatitis C virus– and HIV-
infected patients responding to antiviral therapy 
(10–12). In marked contrast, memory T cells 
generated to an acutely resolved infection sur-
vive in the absence of antigen (13, 14). The 
reason for this discrepancy is unknown.
Various models have been constructed to 
understand antigen-driven diff  erentiation  of 
naive T cells (15). These models are based on 
phenotypic changes within a T cell population, 
and they rely on the assumption that individual 
cells analyzed in the end are the progeny of 
cells sampled in the beginning. Any input of 
primed cells into the population after the initial 
readout complicates the delineation of diff  er-
entiation pathways.
We sought to gain a clearer understanding 
of the dichotomy of antigen dependence for 
antiviral CD8 T cell survival during chronic 
infection by examining the impact of persistent 
antigen on T cell priming, phenotype, and sur-
vival. In this paper, we demonstrate that after 
initial CD8 T cell priming, which occurs early 
after viral exposure, the presence of persistent 
antigen recruits new, naive antigen-specifi  c 
CD8 T cells. Because these T cells are phe-
notypically distinct from those primed earlier, 
they contribute to the diversity seen within 
populations of chronic viral antigen-specifi  c 
CD8 T cells. Collectively, our data that anti-
viral CD8 T cells in chronic infection are de-
fective in homeostatic proliferation, and that 
thymectomy results in a loss of virus-specifi  c 
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CD8 T cells, indicate a novel role for antigen in maintaining 
CD8 T cells in persistent infection.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Polyoma virus (PyV) establishes a systemic persistent infec-
tion in mice (Fig. 1 A) (7). CD8 T cell responses to PyV in-
fection are detected via binding of Db tetramers complexed 
to an immunodominant epitope encoded by aa 359–368 of 
the viral large T protein (LT359) (Fig. 1, B and C). After the 
acute phase of infection, LT359-specifi  c CD8 T cells are de-
tected as late as 560 d after infection (Fig. 1 B). At 246 d after 
infection, this population of antigen-specifi  c cells is hetero-
geneous for expression of CD27, CD62L, CD127, and bcl-2 
(Fig. 1 C). In addition, viral DNA is detectable in the spleen 
and other organs for at least that length of time (Fig. 1 A and 
not depicted) (7). We asked whether this phenotypic hetero-
geneity represented diff  erentiation of cells primed during the 
acute phase of infection or resulted from an amalgam with 
cells newly generated during persistent infection.
We assessed the capacity of antiviral CD8 T cells to 
survive during persistent infection. T cells from mice in-
fected by PyV 150 d earlier were transferred into   infection-
matched congenic hosts (Fig. 2 A). LT359-specifi  c  CD8 
T cells of both host and donor origin were monitored 
over time. Whereas host CD8 T cells were maintained at 
a constant level, donor cells decreased over time (Fig. 2 B); 
the most rapid decline occurred over the fi  rst 3 wk, followed 
by a slower rate of attrition. This fi  nding was unexpected be-
cause of the slower kinetics of virus-specifi  c CD8 T cell loss 
during persistent infection in unmanipulated mice (Fig. 1 B). 
The transferred cells did not divide over 34 d (Fig. 2 C), 
although PyV-infected mice support homeostatic division 
of conventional memory CD8 T cells (Fig. 2 D), indicating 
that this cell loss is a cell-intrinsic phenomenon. Similarly, 
CD8 T cells from mice persistently infected by lymphocytic 
choriomeningitis virus (LCMV) fail to undergo homeostatic 
proliferation when transferred to naive mice (9). Because 
the PyV-specifi  c host and donor CD8 T cells were elicited 
and maintained under identical conditions in this transfer 
  experiment and coexist in the same environment, this data 
Figure 1.  Visualizing PyV infection. (A) Splenic PyV DNA levels ± 
SEM over time. (B) Number of splenic Db-LT359 tetramer+ CD8 T cells ± 
SD over time. (C) Splenic CD8 T cell responses 246 d after infection. Plots 
are gated on CD8 T cells, and values refl  ect the percentage of tetramer+ 
cells in each quadrant (n = 3–9 mice).
Figure 2.  Loss of PyV-specifi  c CD8 T cells in an antigen-bearing 
host. (A) Experimental setup. (B) Host mice were bled at day 4 after trans-
fer to establish a base level of Db-LT359 tetramer+ cells of donor and host 
origin. PBLs were monitored over time, and values indicate the percentage 
of tetramer+ cells ± SEM of either host or donor origin normalized for 
input at day 4 after transfer (n = 4 mice). Two independent experiments 
were performed. The donor tetramer+ cell frequencies varied from 0.3–0.6% 
of CD8 T cells at day 4, and host tetramer+ frequencies varied from 
1.3-3.8% of CD8 T cells. (C) Transferred PyV-specifi  c cells were monitored 
over time for CFSE fl  uorescence. Plots are gated on donor tetramer+ cells. 
Values indicate the percentage of cells within the marked regions. (D) CFSE-
labeled memory P14 cells were transferred to naive congenic mice (n = 3) 
or congenic mice infected by PyV 200 d earlier (n = 4). Spleens of sec-
ondary hosts were analyzed 36 d later. Plots are gated on P14 cells.JEM VOL. 203, October 2, 2006  2265
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is   inconsistent with the concept that antigen maintains the 
survival of antiviral CD8 T cells during chronic infection. To 
reconcile this discrepancy, we reasoned that host cells, but not 
donor cells, can be resupplied through thymic output, and 
perhaps new, naive PyV-specifi  c CD8 T cells were being gen-
erated and subsequently primed during persistent infection.
To test this hypothesis, we induced partial hematopoietic 
chimerism in persistently infected mice using congenic bone 
marrow (Fig. 3 A). Such animals now have stem cells that 
give rise to a population of naive CD8 T cells distinguished 
either by host or donor allelic diff  erences (Fig. 3 B). This 
protocol permits stem cell engraftment without irradiation, 
thereby limiting the perturbance of viral load or established 
T cell populations, as preexisting PyV-specifi  c T cells are not 
aff  ected by busulfan treatment alone (unpublished data) (7). 
Moreover, the emergence of donor naive T cells beginning 
at  1 mo after busulfan conditioning is thymus dependent 
(16). Additionally, this protocol does not replace all bone 
marrow stem cells, and the population of newly developing 
T cells will be a mix of donor and host cells. 50 d after infu-
sion of congenic bone marrow in busulfan-conditioned mice 
infected by PyV 115 d previously, animals were analyzed 
for PyV-specifi  c CD8 T cells. As shown in Fig. 3 C, host-
derived tetramer+ cells were detected in chimeric animals. 
Interestingly, a population of PyV-specifi  c CD8 T cells origi-
nating from the donor population was also detected. This 
was not caused by contaminating naive or memory CD8 
T cells in the donor cell inoculum, because transfer of the 
same number of bone marrow cells or splenocytes without 
busulfan did not generate a detectable donor cell population 
(Fig. 3 B). It has been estimated that thymic education occurs 
over the course of 3–4 wk (17). This is consistent with the 
inability to detect donor antigen-specifi  c T cells earlier than 
30 d after busulfan conditioning (unpublished data). Recruit-
ment of recent thymic emigrants during the persistent stage 
of infection was not limited to PyV infection. We performed 
the same chimeric induction protocol in mice infected 120 d 
earlier by LCMV clone 13; at this time point, LCMV is 
only detected in the kidneys and brain (3). It is important 
to mention that this LCMV–mouse model is diff  erent from 
other models of persistent LCMV infection in which virus is 
detectable in the thymus (e.g., congenitally infected carrier 
mice, CD4-depleted LCMV clone 13–infected adult mice, 
and LCMV clone 13–infected adult mice approximately day 
Figure 3.  Priming of new, naive antiviral CD8 T cells during persis-
tent infection. (A) Partial bone marrow chimerism protocol. (B) Mice 
infected by PyV 84 d earlier were either injected with splenocytes or bone 
marrow cells or treated with busulfan and injected with bone marrow 
cells the next day (n = 3–8 mice). Spleens were analyzed 42 d later and 
assessed for chimerism. Each plot contains 105 events, and values repre-
sent the percentage of lymphocytes within the indicated regions. (C) Mice 
infected by PyV 115 d earlier were treated with busulfan and injected with 
bone marrow cells as in A. Organs were analyzed for Db-LT359 tetramer+ 
CD8 T cells 51 d after cell transfer. Plots are gated on donor or host CD8 
T cells, and values indicate the percentage of tetramer+ cells. 10 and 8% 
of tetramer+ cells are of donor origin in the spleen and lung, respectively. 
(D) Mice infected by LCMV clone 13 120 d earlier were treated with busul-
fan and received bone marrow cells as in A. Organs were analyzed for 
Db-gp276 tetramer+ CD8 T cells 48 d after cell transfer (n = 6). Plots are 
gated on host or donor CD8 T cells, and values represent the percentage 
of CD8 T cells that are tetramer+. 7.5 and 9.4% of tetramer+ cells are of 
donor origin in the liver and lung, respectively. (E) Naive mice were thy-
mectomized (thymx; n = 8) or sham operated (sham; n = 6). 45 d after 
PyV infection, spleens were analyzed for tetramer+ cells. The experiment 
was repeated twice with a combined p-value of 0.04.2266  CONSTANT NAIVE T CELL PRIMING IN CHRONIC INFECTION | Vezys et al.
30 after infection) (18, 19), but it more closely approximates 
the low-level viral replication seen in persistent PyV infec-
tion and many persistent viral infections in humans. Fig. 3 D 
depicts the presence of donor and host LCMV-specifi  c CD8 
T cells in chimeric animals.
To assess the contribution of newly primed T cells to the 
long-term pool of antiviral CD8 T cells, we thymectomized 
naive mice and determined the number of PyV-specifi  c CD8 
T cells after infection. Thymectomy signifi  cantly reduced the 
number of tetramer+ CD8 T cells (Fig. 3 E). This is consis-
tent with our interpretation that continuous priming of new 
thymic emigrants is required for the maintenance of the pop-
ulation of virus-specifi  c CD8 T cells. Our data also support 
the conclusions of a recent study exploring the contribution 
of thymic emigrants to the CD4 T cell response, where pro-
longed antigen presentation occurs, despite the lack of infec-
tious virus (20).
Because the T cell priming environment may vary be-
tween acute and persistent phases of infection and diff  eren-
tially aff  ect T cell programming, we also analyzed PyV-specifi  c 
CD8 T cells for the expression of markers of diff  erentiation. 
As shown in Fig. 4 A, there are variations in expression of 
CD27, CD62L, CD127, and bcl-2 between the cell popula-
tions primed at diff  erent times. When the expression of either 
CD27 or CD62L is monitored over time on the bulk popul-
ation of PyV-specifi  c T cells, an interesting pattern emerges 
Figure 4.  Dynamic phenotype of PyV-specifi  c CD8 T cells. Mice 
infected by PyV 35 (A) or 95 (C) d earlier received busulfan and bone mar-
row cells as in Fig. 3 A. Organs were analyzed for tetramer+ CD8 T cells 
45 (A) or 140 (C) d after cell transfer. Plots are gated on tetramer+ cells. 
Host cells (black), donor cells (red), and host CD44lo CD8 T cells (blue) are 
shown. In A, 6–7% of tetramer+ cells are of donor origin; in C, 5–6% of 
tetramer+ cells are of donor origin (n = 3–8 mice). SPL, spleen; LG, lung. 
(B) CD27 and CD62L expression on splenic tetramer+ cells over time. 
Plots are gated on CD8 T cells, and values in plots indicate the percentage 
of tetramer+ cells that express high levels of either CD27 or CD62L. The 
plot for CD62L at day 246 is the same as in Fig. 1 C (n = 3–12 mice per 
time point).JEM VOL. 203, October 2, 2006  2267
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(Fig. 4 B). At the peak of CD8 T cell expansion, the majority 
of cells are CD27hi. These cells quickly down-regulate sur-
face expression of this molecule, but the proportion of 
CD27hi cells progressively increases over time. By 560 d after 
infection, the majority of PyV-specifi   c CD8 T cells are 
CD27hi. A similar pattern is observed with CD62L. This is 
consistent with the concept that newly primed T cells, being 
CD27hi and CD62Lhi (Fig. 4 A), are productively contribut-
ing to the pool of antigen-specifi  c CD8 T cells and modify 
the phenotype of the entire virus-specifi  c CD8 T cell popu-
lation. Current evidence suggests that CD27lo T cells do not 
regain expression of CD27 and preferentially die (21). The 
data in Fig. 4 (A and B) are in line with the interpretation that 
the CD27lo PyV-specifi  c CD8 T cell population is undergo-
ing progressive attrition. Because PyV antigen is present up 
to 300 d after infection (Fig. 1 A), it is likely that antigen 
modifi  es the population of tetramer+ cells in at least two 
ways: antigen is required to prime recent thymic emigrants, 
which have a CD27hi CD62Lhi phenotype, but antigen can 
also induce down-regulation of CD27 and CD62L. Antigen-
independent events may modulate the expression of these 
molecules as well.
Newly recruited antiviral CD8 T cells may diff  er qualita-
tively from their older counterparts. We have found that the 
number of newly primed cells making IFN-γ closely corre-
sponds to the number of Db-LT359 tetramer+ cells (unpub-
lished data). A comprehensive comparison of the functional 
attributes of new and old antiviral CD8 T cells should prove 
particularly informative in elucidating the contribution of 
each cell population to viral control.
Analysis of chimeric animals at late time points (Fig. 4 C) 
reveals a narrowing in the phenotype of virus-specifi  c CD8 
T cells primed over the course of persistent infection (com-
pare with Fig. 4 A). Although some diff  erences are still appar-
ent, such as bcl-2 levels, by 140 d after induction of chimerism, 
splenic CD27 levels by host and donor PyV-specifi  c T cells 
are similar. Because chimerism induction does not displace 
the original host stem cells (Fig. 3 B), new naive T cells can 
originate from either donor or recipient precursors. The 
priming environment is also dynamic over time in terms of 
antigen load and virus-associated infl  ammation, with these 
changes aff  ecting the strength and frequency of T cell activa-
tion and, therefore, longevity. Jelley-Gibbs et al. recently 
demonstrated that infl  uenza  virus–specifi   c CD4 T cells 
primed late in the response survive better than those recruited 
earlier, suggesting that early and protracted antigen encoun-
ter is detrimental to T cell survival (20). Collectively, these 
fi  ndings imply that many of the virus-specifi  c CD8 T cells 
late in persistent infection may be derived from more re-
cently primed cells.
Recent studies indicate a dependence on antigen for 
maintenance of antiviral CD8 T cells in chronic infections, 
although there are some exceptions (8–10, 22). Our data 
demonstrate that new, naive virus-specifi  c CD8 T cells are 
primed to viral antigens long after initial infection. Priming 
of newly emerging CD8 T cells to persisting antigens has 
been suggested before, and a recent report shows de novo 
CD4 T cell responses to chronic infections in baboons after 
autologous bone marrow transplant (23–25). In a chronic 
LCMV infection model, continuous thymic output does not 
appear to be required to maintain CD8 T cell responses, al-
though a T cell defi  cit was observed at day 30 after infection 
(26). In contrast, thymectomy is associated with loss of CTL 
activity in cats persistently infected by a feline lentivirus (27). 
Our data are consistent with reports describing antigen de-
pendence for chronic pathogen-specifi  c T cell maintenance, 
especially as newly primed cells may be important for pre-
serving the population of virus-specifi  c T cells (Fig. 3 E) 
(8–12). Moreover, the new, naive antigen-specifi  c CD8 T 
cells are able to survive thymic education, despite persisting 
antigen, and exit to the periphery.
It has been suggested that memory-like CD8 T cells in 
chronic infections go through an abortive diff  erentiation 
pathway, as dissected through phenotypic analysis of CD8 
T cells in infected individuals (4, 15, 28). The lineage rela-
tionship between these stages is comprehensible only if the 
end cell stems from the beginning cell or its progeny. Our 
data indicate that new naive cells are continuously being re-
cruited during the chronic phase of infection and that the 
time point of priming infl   uences the phenotype of CD8 
T cells. These observations aff  ect our understanding of T cell 
diff   erentiation pathways during chronic infections, as the 
T cell population analyzed will potentially contain cells 
primed at any time after infection.
In summary, we propose that ongoing selection and 
priming of naive CD8 T cells during persistent infection con-
tributes to the maintenance of chronic memory-like cells. 
Phenotypic heterogeneity indicates programming diff  erences 
in cells primed more recently, and their continual entry into 
the virus-specifi  c T cell reservoir complicates interpretation 
of current models of lineage diff  erentiation. In other situa-
tions in which antigen persists, such as cancer, autoimmunity, 
and organ transplantation, it will be important to address 
whether naive T cells continue to be recruited. Our fi  ndings 
may off  er new avenues for therapeutic vaccination, as newly 
recruited cells may be more amenable to boosting strategies.
MATERIALS AND METHODS
Mice. C57BL/6 (B6) female mice were purchased from the National Can-
cer Institute. B6/CD45.1 female mice were purchased from Taconic or bred 
in our facility. P14 transgenic mice bearing the TCR specifi  c for the gp33-
41 epitope of LCMV were bred on a B6/CD90.1 background in our facility. 
All mice were used between 4 and 10 wk of age. Thoracic thymi were re-
moved from anesthetized mice, which were rested for at least 2 wk before 
infection. All protocols for animal studies were approved by the Institutional 
Animal Care and Use Committee of Emory University.
Viral DNA detection. DNA was extracted from frozen tissue using a 
DNA mini kit (QIAamp; QIAGEN). PyV genomic copy numbers were de-
termined by quantitative PCR (TaqMan; Glen Research Corporation), as 
described previously (7). PyV DNA quantity is expressed in genome copies 
per milligram of tissue and is calculated based on a standard curve of known 
PyV genome copy numbers versus threshold cycle of detection. The detec-
tion limit with this assay is 10 copies of genomic viral DNA.2268  CONSTANT NAIVE T CELL PRIMING IN CHRONIC INFECTION | Vezys et al.
Viruses and cell transfers. Mice were infected with 2 × 106 PFU of PyV 
(strain A2) s.c.; 2 × 106 PFU LCMV clone 13 was administered i.v. Spleens 
from PyV-infected mice were harvested at the indicated time points and de-
pleted of IgG+ cells by panning on plates coated with anti-IgG antibodies 
(The Jackson Laboratory). Cells were labeled with 5 μM CFSE (Invitrogen) 
for 10 min at 37°C. 50 × 106 CFSE-labeled cells were transferred to infection-
matched congenic hosts. Naive B6/CD90.2 mice received 5 × 105 naive 
P14 cells i.v. 1 d before i.p. infection by 2 × 105 PFU of LCMV-Armstrong. 
120 d after infection, memory P14 cells were isolated from spleens and 
  labeled with CFSE, and 20 × 106 cells were transferred to naive B6/CD90.2 
mice or B6/CD90.2 mice infected by PyV 200 d earlier.
Cell isolation and fl  ow cytometry. Femurs and tibias were crushed to 
isolate bone marrow cells. Single cell suspensions were made of RBC-lysed 
spleens. Animals were perfused before lung and liver isolation. Lung pieces 
were treated with EDTA and digested with collagenase with subsequent 
density centrifugation to isolate lymphocytes, as previously described (29). 
Single-cell suspensions were made from liver by passing tissue through nylon 
mesh, followed by density centrifugation to isolate lymphocytes (29). Anti-
bodies to CD8, CD90.1, and bcl-2 were purchased from Becton Dickinson 
and used according to the manufacturer’s specifi   cations. Antibodies to 
CD27, CD45.1, CD45.2, CD62L, and CD127 were purchased from eBio-
science. Antibodies to KLRG1 were purchased from Southern Biotechnol-
ogy Associates, Inc. Tetramers were constructed as previously described (7). 
All samples were collected on a FACSCalibur (BD Biosciences) and analyzed 
with FlowJo software (Tree Star, Inc.).
Bone marrow chimerism induction. Mice persistently infected either by 
PyV or LCMV clone 13 at least 35 d earlier received 600 μg busulfan i.p. 
(Busulfex; Orphan Medical). The next day, 25 × 106 cells isolated from the 
bone marrow of congenic mice were injected i.v.
Statistical analysis. Statistical signifi  cance for individual experiments was 
determined using the unpaired Student’s t test. The Mack-Skillings test was 
used to determine statistical signifi  cance of multiple experiments. A p-value 
≤0.05 was considered statistically signifi  cant.
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